作者: Pramod A Dhebade , Shekhar Ashok Deshmukh , Changdev Namdev Raut
DOI:
关键词: Pharmacology 、 Nuclear chemistry 、 Powder diffraction 、 GARENOXACIN MESYLATE 、 Materials science
摘要: The present invention provides garenoxacin mesylate crystalline form characterized by an X-ray powder diffraction pattern with peaks at about 13.77, 20.54, 21.50, 21.77, 22.12 and 23.90 ± 0.2 °θ.